These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8870809

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of an aldose reductase inhibitor on erythrocyte fructose 3-phosphate and sorbitol 3-phosphate levels in diabetic patients.
    Hamada Y, Odagaki Y, Sakakibara F, Naruse K, Koh N, Hotta N.
    Life Sci; 1995; 57(1):23-9. PubMed ID: 7596218
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.
    Hotta N, Kakuta H, Koh N, Fukasawa H, Yasuma T, Awaya S, Sakamoto N.
    Diabetes Res Clin Pract; 1991 Oct; 14(1):29-35. PubMed ID: 1748061
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes.
    Sobajima H, Aoki T, Sassa H, Suzuki T, Taniko K, Makino M, Mizuno K, Suzuki T.
    Pharmacology; 2001 May; 62(4):193-9. PubMed ID: 11359994
    [Abstract] [Full Text] [Related]

  • 9. Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
    Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N.
    Diabetes Care; 2000 Oct; 23(10):1539-44. PubMed ID: 11023149
    [Abstract] [Full Text] [Related]

  • 10. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats.
    Hotta N, Kakuta H, Fukasawa H, Kimura M, Koh N, Iida M, Terashima H, Morimura T, Sakamoto N.
    Diabetologia; 1985 Mar; 28(3):176-80. PubMed ID: 3922829
    [Abstract] [Full Text] [Related]

  • 11. Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.
    Asano T, Saito Y, Kawakami M, Yamada N, Fidarestat Clinical Pharmacology Study Group.
    J Diabetes Complications; 2002 Mar; 16(2):133-8. PubMed ID: 12039395
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma.
    Takiguchi Y, Wada K, Nakashima M.
    Eur J Pharmacol; 1992 May 14; 215(2-3):289-91. PubMed ID: 1396993
    [Abstract] [Full Text] [Related]

  • 15. Polyol pathway in tissues of spontaneously diabetic Chinese hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235.
    Sekiguchi M, Watanabe K, Eto M, Iwashima Y, Morikawa A, Takahashi M, Ishii K, Makino I.
    Comp Biochem Physiol B; 1991 May 14; 98(4):637-40. PubMed ID: 1907900
    [Abstract] [Full Text] [Related]

  • 16. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
    Ishibashi Y, Matsui T, Matsumoto T, Kato H, Yamagishi S.
    Diab Vasc Dis Res; 2016 Jul 14; 13(4):312-5. PubMed ID: 27190083
    [Abstract] [Full Text] [Related]

  • 17. Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
    Isogai S, Inokuchi T, Ohe K.
    Diabetes Res Clin Pract; 1995 Nov 14; 30(2):111-6. PubMed ID: 8833631
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
    Poulsom R, Mirrlees DJ, Earl DC, Heath H.
    Exp Eye Res; 1983 May 14; 36(5):751-60. PubMed ID: 6406254
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.